RXST
Rxsight IncNASDAQHEALTHCAREMEDICAL DEVICES
Key Statistics
Market Cap
$300.42M
P/E Ratio
—
EPS
$-0.95
Beta
1.21
52W High
$16.74
52W Low
$5.90
50-Day MA
$7.77
200-Day MA
$9.19
Dividend Yield
—
Profit Margin
-29.00%
Forward P/E
116.28
PEG Ratio
—
About Rxsight Inc
Rxsight Inc. is a pioneering healthcare technology company specializing in advanced vision correction solutions through its innovative diagnostic and surgical techniques in refractive eye surgery. Utilizing proprietary software and precision-guided laser technology, the company significantly improves patient outcomes and overall quality of life. Rxsight's strong intellectual property portfolio and strategic partnerships further enhance its competitive positioning within the expanding ophthalmic market. With a robust commitment to innovation and excellence, Rxsight is strategically poised for significant growth and impact in the evolving landscape of eye care.
Fundamentals
| Revenue (TTM) | $134.48M |
| Gross Profit (TTM) | $103.01M |
| EBITDA | $-44.92M |
| Operating Margin | -34.80% |
| Return on Equity | -14.00% |
| Return on Assets | -9.56% |
| Revenue/Share (TTM) | $3.29 |
| Book Value | $6.68 |
| Price-to-Book | 0.99 |
| Price-to-Sales (TTM) | 2.23 |
| EV/Revenue | 0.423 |
| EV/EBITDA | -7.70 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -18.90% |
| Shares Outstanding | $41.27M |
| Float | $36.93M |
| % Insiders | 5.64% |
| % Institutions | 90.04% |
Analyst Ratings
Consensus ($10.21 target)
1
Strong Buy8
Hold2
Strong SellData last updated: 4/9/2026